期刊文献+

白介素-11治疗系统性红斑狼疮血小板减少症的疗效观察 被引量:3

下载PDF
导出
摘要 系统性红斑狼疮常累及血液系统,其中血小板减少最多见,发生率为7%-26%,其中严重血小板减少(血小板≤40×10^9/L)发生率为5%~10%,是系统性红斑狼疮死亡的重要原因。Feinglass等^[1]曾报道1例系统性红斑狼疮所致的血小板减少症应用白介素11(IL-11)取得了满意的疗效.我们曾将IL-11应用于4例系统性红斑狼疮所致的血小板减少症,治疗有效,现将其报告如下。
出处 《实用医学杂志》 CAS 2007年第24期3971-3971,共1页 The Journal of Practical Medicine
  • 相关文献

参考文献3

二级参考文献30

  • 1许蔚林,虞积仁.血小板生成素研究新进展[J].中华内科杂志,1996,35(9):635-637. 被引量:3
  • 2单渊东,张之南.系统性红斑狼疮的血液学改变.见:蒋明,朱立平,林孝义,主编.风湿病学.北京:科学技术出版社,1995.699.
  • 3Long MW.Population heterogeneity among cells of the megakaryocyte lineage.Stem Cells,1993,11:33-40.
  • 4Edward B,Ronald H.Human megakaryocyte progenitor cells.Semin Hematol,1998,35:183-191.
  • 5Briddell RA,Brandt JE,Straneva JE,et al.Characterization of the human burst forming unit-megakaryocyte.Blood,1989,74:145-151.
  • 6Briddell RA,Hoffman R.Cytokine regulation of the human burst forming unit-megakaryocyte.Blood,1990,76:516-522.
  • 7Wallace DJ,Dubois EL.In:Wallace DJ,Dubois EL,eds.Dubois Lupus Erythematosus.3rd ed.Philadelphia:Lea & Fediger,1987.438-439.
  • 8Hunt P.A bipotential megakaryocyte/erythrocyte progenitor cell:the link between erythropoiesis and megakaryopoiesis becomes stronger.J Lab Ciln Med,1994,123:610-616.
  • 9Han ZC.Identification of a murine high proliferative potential colony forming cell capable of producing a number of megakaryocytes and replating for secondary HPP-CFCs in culture.J Lab Clin Med,1994,123:610-616.
  • 10Debili N,Coulombel L,Croisille L,et al.Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow.Blood,1996,88:1284-1296.

共引文献24

同被引文献39

  • 1赵永强,王庆余,翟明,徐健,陈协群,刘文励,张梅,宋善俊,王健民,孟凡义,单渊东.重组人血小板生成素治疗慢性难治性特发性血小板减少性紫癜的多中心临床试验[J].中华内科杂志,2004,43(8):608-610. 被引量:102
  • 2Jazayeri JA, Carroll GJ, Vernallis AB. Interleukin-6 subfamily eytokines and rheumatoid arthritis: role of antagonists [ J]. Int Immunopharmacol, 2010, 10( 1 ) : 1-8.
  • 3Putoczki T, Ernst M. More than a sidekick: the IL-6 family cy- tokine IL-11 links inflammation to cancer [ J ]. J Leuko Biol, 2010,88(6) : 1109-1117.
  • 4Peterson H, Abu Dawud R, Garg A, et al. Qualitative modeling identifies IL-11 as a novel regulator in maintaining self-renewal in human pluripotent stem cells [J]. Front Physiol, 2012, 4: 303.
  • 5Ernst M, Thiem S, Nguyen PM, et al. Epithelial gp130/Stat3 functions: An intestinal signaling node in health and disease [J]. Semin Immunol, 2014,26 ( 1 ): 29- 37.
  • 6Aitsebaomo J, Srivastava S, Zhang H, et al. Recombinant hu- man intedeukin-ll treatment enhances collateral vessel growth after femoral artery ligation [J].Arterioseler Thromb Vase Biol, 2011,31 (2) :306-312.
  • 7McCoy EM, Hong H, Pruitt HC, et al. IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells [J]. BMC Cancer, 2013,13 (1):16.
  • 8Souza PPC, Lemer UH. The role of cytokines in inflammatory bone loss [J]. Immunol Investigat, 2013,42(7) :555-622.
  • 9Elsaeidi F, Bemben MA, Zhao XF, et al. Jak/Stat signaling stimulates zebrafish optic nerve regeneration and overcomes the inhibitory actions of Sots3 and Sfpq [J]. J Neurosci, 2014,34 (7) : 2632-2644.
  • 10Menkhorst E, Salamonsen L, Robb L, et al. IL11 antagonist in- hibits uterine stromal differentiation, causing pregnancy failure in mice [ J ]. Biol Reprod, 2009,80 (5) : 920-927.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部